Safety and Efficacy of NNC-0156-0000-0009 after Long-Term Exposure in Patients with Haemophilia B
- Conditions
- blood clotting disorderHaemophilia B10064477
- Registration Number
- NL-OMON39320
- Lead Sponsor
- ovo Nordisk
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 3
Previous participation in Paradigm2 or Paradigm3
* Known history of FIX inhibitors based on existing medical records, laboratory report reviews and patient and LAR interviews
* Current FIX inhibitors *0.6 BU
* Congenital or acquired coagulation disorders other than haemophilia B
* Previous arterial thrombotic events (e.g. myocardial infarction and intracranial thrombosis) or previous deep venous thrombosis or pulmonary embolism (as defined by available medical records)
* Any disease (liver, kidney, inflammatory and mental disorders included) or condition which, according to the Investigator*s judgement, could imply a potential hazard to the patient, interfere with trial participation, or interfere with trial outcome
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method